Veripath Q4 2023 Fund Factsheet

Veripath Q4 2023 Fund Factsheet

Veripath R & UR Funds Q4 2023 – NAVs, fund metrics View full report
Read more...
Veripath Q3 2023 Fund Factsheet

Veripath Q3 2023 Fund Factsheet

Veripath R & UR Funds Q3 2023 – NAVs, fund metrics View full report
Read more...
Veripath Q3 2023 – Investor Letter

Veripath Q3 2023 – Investor Letter

Veripath continues to generate compelling risk-adjusted returns and a recent $60M acquisition of irrigated land in Alberta brings total assets under management (AUM) to over $350M
Read more...
Corpus, Averine & Preceptos Partners Q2 2023 Investor Updates

Corpus, Averine & Preceptos Partners Q2 2023 Investor Updates

We are pleased to present the report to unitholders for the quarter ended June 30, 2023.
Read more...
Veripath Q2 2023 – Investor Letter

Veripath Q2 2023 – Investor Letter

Veripath’s investors have confidence that our non-operated farmland thesis rests on a foundation of well researched elements.
Read more...
Q1 2023 Portfolio Operating Partnership Strategy Update

Q1 2023 Portfolio Operating Partnership Strategy Update

Update on the portfolio operating partneship strategy - Averine (royalties), Corpus (healthcare) and Preceptos (light industrial).
Read more...
Veripath Q1 2023 Fund Factsheet

Veripath Q1 2023 Fund Factsheet

Veripath Fact Sheet Q4 2022 – Check the complete report below View full report
Read more...
Veripath Q1 2023 Newsletter

Veripath Q1 2023 Newsletter

Q1 2023 Newsletter – Canadian farm productivity will be positively impacted by global warming – Check the complete report below View full report
Read more...
Veripath Fact Sheet Q4 2022

Veripath Fact Sheet Q4 2022

Veripath Fact Sheet Q4 2022 – Check the complete report below View full report
Read more...
1 2 3 4 5 6 7